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OBJECTIVE: With the progression of the renal insufﬁ-
ciency (RI) produced in the chronic allograft nephropa-
thy (CAN), the patients’ HRQoL worsens. The treatment
of the anemia associated to the RI with rh-EPO improves
the HRQoL. The objective of present study was to eval-
uate the HRQoL of kidney transplant patients with CAN
and anemia associated to the RI, and the effect of the
treatment with rh-EPO on the HRQoL. METHODS:
Prospective study of 24 kidney transplant patients with
RI caused by CAD and anemia who received rh-EPO to
treated the anemia. The hemoglobin target was 12gr/dL.
HRQoL was evaluated with the SF-36 Health Survey at
start treatment, 3 months later and at the end of follow-
up. SF-36 scores (8 dimensions, Physical-PCS and Mental
Component Summary-MCS) were standardized by age
and gender using the Spanish general population norms.
The “Effect Size” was also calculated for each dimension
and for summary scores. RESULTS: Hemoglobin statisti-
cally improved from start to third month (p < 0.01). SF-
36 scores of studied patients were worse than those of the
general population and that those of a transversal sample
of transplant patients with good renal function: PCS =
36.08 ± 12.83 vs. 48.68 ± 9.86; MCS = 47.16 ± 14.46
vs. 51.91 ± 10.25. Three SF-36 dimensions statistically
improved with the correction of anemia with the rh-EPO
treatment: Role Physical, Vitality and Mental Health. The
“Effect Size” was very small for Physical Functioning and
Social Functioning; small for General Health (0.28) and
PCS (0.23); moderate for Pain (0.41), Role Emotional
(0.39) and MCS (0.42); and large for Role Physical
(0.65), Vitality (0.81) and Mental Health (0.74). CON-
CLUSIONS: The poor HRQoL of kidney transplant
patients with CAN and anemia improves with the treat-
ment of the anemia with rh-EPO. The “Effect Size” for
this change in the HRQoL is moderate to large in major-
ity of HRQoL areas.
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OBJECTIVE: A great proportion (50–70%) of patients
with urinay incontinence (UI) do not ask for medical
advise. Symptom questionnaires may help in detecting the
UI. The objective of present study was to analize the psy-
chometric properties of the Spanish version of the ques-
tionnaire of UI symptoms “ICIQ-SF”. METHODS: A
total of 500 women who consulted at a UI-specialized
unit answered the questionnaire. Urodinamic study was
carried out, and sociodemographic and clinical data were
also collected including the symptoms expressed by the
patients. So there were two diagnostic tools for the assess-
ment: clinical and that of the urodinamic study. Feasibil-
ity, validity (comparing the scores between groups ac-
cording to both diagnostic methods, between goups of
different sort of UI and between groups of different sever-
ity degrees) and reliability (Cronbach’s alpha) were
assessed. Sensitivity (Se), speciﬁcity (Sp), positive (PPV)
and negative (NPV) predictive value with respect to clin-
ical diagnostic and that of the urodinamic study were also
calculated. RESULTS: Mean time of administration was
3 minutes. All patients answered all the items of the ICIQ-
SF. According to clinical diagnostic, patients with UI
showed higher score on the ICIQ-SF (11.6 ± 5.9) than
women without UI (4.5 ± 6.3) (p = 0.000). The same
occurs with the groups according to the urodinamic study
(11.1 ± 6.3 vs. 6.2 ± 6.5; p = 0.000). A higher severity
degree was associated to a higher score on the ICIQ-SF:
low degree (10.47 ± 5.61) vs. intermediate (12.4 ± 5.72)
vs high degree (13.61 ± 5.42). Cronbach’s alpha was 0.89.
The values of Se, Sp, PPV and NPV were 92.1%, 55.6%,
88.3% y 65.9% with respect to clinical diagnostic and
87.7%, 40.8%, 85.1% y 46.2% with respect to the uro-
dinamic study. CONCLUSIONS: This is the ﬁrst ques-
tionnaire design for diagnostic of UI validated in Spain.
The psychometric properties of the ICIQ-SF are satisfac-
tory and allow to recommend the use of the questionnaire
in the clinical practice.
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OBJECTIVE: To evaluate the HRQoL of the patients
who started RRT in our region during last 2 years (N =
284) following them along the time and searching for 
differences between elderly (≥65 years) and younger
patients. METHODS: Preliminary results of 66 patients
who remained in HD during one year are shown. Patients
excluded: a total of 8 because of cognitive deterioration.
An interview was carried out at three months from start
and one year later, using the SF-36 Health Survey, obtain-
ing a Physical (PCS) and a Mental (MCS) Component
Summary Scores, and the Physical Symptom scale (PSS)
of the Kidney Disease Questionnaire (KDQ). Sociodemo-
graphic and clinical data, Karnofsky Scale and a com-
orbidity index were also collected. SF-36 scores were
standardized using the Spanish general population norms.
RESULTS: Mean age = 66.8 ± 13.1 years (elderly 71.2%);
56% men. The main analytic and clinical parameters did
not change after one year: hemoglobin = 11.5 ± 1 versus
11.1 ± 1.5gr./dL.; Albumin = 3.6 ± 0.2 versus 3.6 ±
0.4gr./L.; Creatinine = 8.13 ± 2.39 versus 7.87 ±
